Skip to content

Clinical trials

Phase 3 Respiratory Tract Diseases trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Country / region: South Korea Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20111
20131
20144
20161
20171
20192
20203
20222
20231
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed12
Recruiting2
Terminated2
Active, not recruiting1
Enrolling by invitation1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca7
Merck Sharp & Dohme LLC2
United Therapeutics2
Bellus Health Inc. - a GSK company1
Eli Lilly and Company1
GlaxoSmithKline1
Hoffmann-La Roche1
LG Life Sciences1
Lifesemantics Corp.1
Mannkind Corporation1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases19
Lung Diseases14
Bronchial Diseases7
Lung Diseases, Obstructive7
Asthma6
Chronic Cough3
Cough3
Infections3
Lung Neoplasms3
Respiration Disorders3

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.